However, a pivotal research in sufferers with surgically resected colorectal cancers Dukes’ stage C randomized to observation or treatment with edrecolomab demonstrated a substantial clinical benefit, i.e., reduced amount of loss of life and recurrence price, and a harmless basic safety profile [27,28]. them for binding affinity, EpCAM epitope identification, […]